ConductScience.org, home

Library / Genes

IRF9: interferon regulatory factor 9

1 protein, 32 patents, 0 drugs, 0 trials, 3,382 NIH grants and 4,853 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolIRF9HGNC
Nameinterferon regulatory factor 9HGNC
NCBI Gene ID10379NCBI Gene
HGNC IDHGNC:6131HGNC
EnsemblENSG00000213928NCBI Gene
AliasesIRF-9, ISGF3, ISGF3G, p48NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q00978Interferon regulatory factor 93930Ensembl, GeneID, HGNCUniProt

Patents 32

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1911425Q00978Espacenet
JP 2025147176 A2025-10-0615177Q00978Espacenet
JP 2025517970 A2025-06-1211425Q00978Espacenet
JP 2025028160 A2025-02-2815177Q00978Espacenet
KR 1020250010750 A2025-01-2115177Q00978Espacenet
JP 2024109657 A2024-08-1415016Q00978Espacenet
JP 2024507735 A2024-02-21220Q00978Espacenet
JP 2023510565 A2023-03-149Q00978Espacenet
US 11564998 B22023-01-316964Q00978Espacenet
US 11446398 B22022-09-2041134Q00978Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3382

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success322,025NIH's project files
P30CA008748Cancer Center Support Grant172,025NIH's project files
R01AI163029Inborn errors of immunity in patients with life-threatening COVID-19172,025NIH's project files
U19AI135972SARS-CoV adaptations through a Systems Biology Lens (SYBIL)142,025NIH's project files
R01AI046712Activation of Macrophages in Human Autoimmune Diseases112,025NIH's project files
R01AR050401Cytokine Balance in Rheumatoid Arthritis112,025NIH's project files
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy112,025NIH's project files
P30CA016058Cancer Center Support Grant92,025NIH's project files
P30CA016672Cancer Center Support Grant92,025NIH's project files
P30CA060553The Robert H. Lurie Comprehensive Cancer Center92,025NIH's project files

Papers 4853

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818937PubTator, text miningPubMed
42794461PubTator, text miningPubMed
42734476PubTator, text miningPubMed
42615604PubTator, text miningPubMed
42582820PubTator, text miningPubMed
42540626PubTator, text miningPubMed
42537903PubTator, text miningPubMed
42521633PubTator, text miningPubMed
42521129PubTator, text miningPubMed
42510838PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license